Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1164/ajrccm.180.4.378 | DOI Listing |
World J Gastrointest Surg
December 2024
Department of Liver and Small Bowel Health, King Faisal Specialist Hospital and Research Centre, Riyadh 11211, Saudi Arabia.
Background: Liver transplantation (LTx) is vital in patients with end-stage liver disease, with metabolic dysfunction-associated steatotic liver disease being the most common indication. Primary sclerosing cholangitis (PSC) is an important indication. Portopulmonary hypertension, associated with portal hypertension, poses a significant perioperative risk, making pretransplant screening essential.
View Article and Find Full Text PDFHepatology
December 2024
Chair, Department of Medicine, University of Arizona, Phoenix, Arizona.
Portopulmonary hypertension (POPH), a form of pulmonary artery hypertension, occurs because of portal hypertension. Pulmonary hemodynamics and right heart function are key entities that are considered when diagnosing and treating POPH. Medical management, combined with liver transplantation, offers a unique opportunity of POPH "cure," however transplant risk can be significant as it relates to the severity of POPH.
View Article and Find Full Text PDFClin J Gastroenterol
December 2024
Department of Gastroenterology and Hepatology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, 514-8507, Japan.
J Clin Med
November 2024
Department of Internal Medicine & Cardiology, Medical University of Warsaw, 02-091 Warsaw, Poland.
: The prevalence of portopulmonary hypertension (PoPH) is relatively low; however, its presence significantly worsens patients' prognosis. When diagnosed, PoPH can be effectively treated, and specific therapies can lead to a substantial reduction in pulmonary circulation pressure, facilitating the safe performance of liver transplantation. Echocardiography is recommended as a first-line method for the non-invasive diagnosis of pulmonary hypertension and serves as a valuable screening tool for patients being evaluated for liver transplantation (LT).
View Article and Find Full Text PDFMayo Clin Proc
November 2024
Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN.
Objective: To determine the prevalence of portopulmonary hypertension in patients referred for liver transplant evaluation.
Methods: Medical records were reviewed for 986 consecutive patients referred for liver transplant evaluation who were screened for pulmonary hypertension with echocardiography from February 1, 2021, to January 31, 2022, across 3 liver transplant centers.
Results: Of 934 patients eligible for analysis, mean (SD) age was 57 (11) years, 558 (59.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!